L-Theanine in the Management of Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The aim of the proposed study is to investigate the efficacy and safety of add-on gamma-glutamylethylamide (L-theanine) versus a placebo for antipsychotic treatment for 8 weeks in a randomized, double-blind, parallel group study of 60 patients with schizophrenia and schizoaffective disorders.
Epistemonikos ID: 1a2bf45039ccc3a04587013410e691ff5c33dea7
First added on: May 04, 2024